Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Devys

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|December 14, 2001
[PTHrP and breast cancer]A Devys, A Lortholary, M Audran
Transplantation Proceedings|November 25, 2010
Biomarkers for the diagnosis of the stable kidney transplant and chronic transplant injury using the ProtoArray® technologyS Le Roux, A Devys, C Girard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2011
Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcomeD Cantarovich, S De Amicis, A Akl, et al.
Anti-Cancer Drug Design|September 1, 1995
Effects of interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF alpha) association in intraperitoneal radioimmunotherapy: studies on an in vitro micrometastasis modelB M Imbert-Marcille, M Berreur, P Thedrez, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 29, 2000
High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patientsM Miédougé, A Devys, M Simon, et al.
Transplantation Proceedings|March 31, 2009
MICA compatibility and immunization in third kidney transplantationsA Cesbron Gautier, A Devys, M L Cheneau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Clinical and Experimental Immunology|January 1, 1997
Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodiesM A Audrain, T A Baranger, N Moguilevski, et al.
International Journal of Cancer|September 17, 1996
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniquesA Devys, P Thedrez, E Gautherot, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|December 14, 2001
[PTHrP and breast cancer]A Devys, A Lortholary, M Audran
Transplantation Proceedings|November 25, 2010
Biomarkers for the diagnosis of the stable kidney transplant and chronic transplant injury using the ProtoArray® technologyS Le Roux, A Devys, C Girard, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2011
Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcomeD Cantarovich, S De Amicis, A Akl, et al.
Anti-Cancer Drug Design|September 1, 1995
Effects of interferon gamma (IFN gamma) and tumor necrosis factor alpha (TNF alpha) association in intraperitoneal radioimmunotherapy: studies on an in vitro micrometastasis modelB M Imbert-Marcille, M Berreur, P Thedrez, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 29, 2000
High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patientsM Miédougé, A Devys, M Simon, et al.
Transplantation Proceedings|March 31, 2009
MICA compatibility and immunization in third kidney transplantationsA Cesbron Gautier, A Devys, M L Cheneau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent haptenM Hosono, M N Hosono, F Kraeber-Bodéré, et al.
Clinical and Experimental Immunology|January 1, 1997
Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodiesM A Audrain, T A Baranger, N Moguilevski, et al.
International Journal of Cancer|September 17, 1996
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniquesA Devys, P Thedrez, E Gautherot, et al.
Pageof 2